These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


617 related items for PubMed ID: 8708120

  • 1. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N, Nagasaka N.
    ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
    [Abstract] [Full Text] [Related]

  • 2. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y, Desager JP, Harvengt C.
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [Abstract] [Full Text] [Related]

  • 3. [Urinary excretion of the catecholamines adrenaline, noradrenaline and dopamine as well as the derivatives metanephrine and normetanephrine in heart disease patients].
    Mäurer W, Yoshida Y, Kübler W.
    Z Kardiol; 1976 Dec; 65(12):1124-38. PubMed ID: 1014804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
    Piöchl E, Käser H, Klein H.
    Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
    [Abstract] [Full Text] [Related]

  • 6. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
    Candito M, Thyss A, Albertini M, Deville A, Politano S, Mariani R, Chambon P.
    Med Pediatr Oncol; 1992 Jan; 20(3):215-20. PubMed ID: 1574031
    [Abstract] [Full Text] [Related]

  • 7. [Urinary excretion of the catecholamines adrenaline, noradrenaline, dopamine, metanephrine and normetanephrine in patients with cardiac insufficiency of I-IV seventy degrees].
    Yoshida Y, Mäurer W, Kübler W.
    Verh Dtsch Ges Kreislaufforsch; 1975 Jan; 41():258-61. PubMed ID: 1231325
    [No Abstract] [Full Text] [Related]

  • 8. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
    Davidson DF, Hammond PJ, Murphy D, Carachi R.
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous quantitation of catecholamines and metabolites in urine.
    de Schaepdryver AF, Moerman EJ.
    Clin Chim Acta; 1978 Mar 15; 84(3):321-8. PubMed ID: 639324
    [Abstract] [Full Text] [Related]

  • 10. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
    Zametkin AJ, Hamburger SD.
    Biol Psychiatry; 1988 Feb 15; 23(4):350-6. PubMed ID: 3342265
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Increase of excretion of urinary catecholamines and its catabolites in a case of pulmonary sarcomatous tumor].
    Candito M, Bekri S, Monpoux P, Parisot F, Mariani R, Chambon P.
    Pathol Biol (Paris); 1992 Dec 15; 40(10):1003-5. PubMed ID: 1299807
    [Abstract] [Full Text] [Related]

  • 13. Catecholamine measurements in pheochromocytoma and neuroblastoma.
    Spiegel HE.
    Ann Clin Lab Sci; 1974 Dec 15; 4(3):174-7. PubMed ID: 4363482
    [No Abstract] [Full Text] [Related]

  • 14. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
    Miano L, Kolloch R, De Quattro V.
    Clin Chim Acta; 1979 Jul 16; 95(2):211-7. PubMed ID: 527220
    [Abstract] [Full Text] [Related]

  • 15. Metabolic adrenergic changes during submaximal exercise and in the recovery period in man.
    Pequignot JM, Peyrin L, Mayet MH, Flandrois R.
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Oct 16; 47(4):701-5. PubMed ID: 511676
    [Abstract] [Full Text] [Related]

  • 16. Urinary catecholamines and metabolites in renal hypertensive dogs.
    Moerman EJ, De Schaepdryver AF.
    J Med; 1972 Oct 16; 3(2):97-102. PubMed ID: 4507073
    [No Abstract] [Full Text] [Related]

  • 17. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF, Grosset K, Grosset D.
    Ann Clin Biochem; 2007 Jul 16; 44(Pt 4):364-8. PubMed ID: 17594783
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Candito M, Soler C, Deville A, Bekri S, Chambon P, Thyss A.
    Med Pediatr Oncol; 1996 Jan 16; 26(1):57-60. PubMed ID: 7494513
    [Abstract] [Full Text] [Related]

  • 19. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G, Brown S, Peitzsch M, Pelzel D, Lattke P, Glöckner S, Stell A, Prejbisz A, Fassnacht M, Beuschlein F, Januszewicz A, Siegert G, Reichmann H.
    Ann Clin Biochem; 2014 Jan 16; 51(Pt 1):38-46. PubMed ID: 23873873
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes in catecholamine metabolites of human urine from birth to adulthood.
    Dalmaz Y, Peyrin L, Sann L, Dutruge J.
    J Neural Transm; 1979 Jan 16; 46(2):153-74. PubMed ID: 512651
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.